Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and the Risk of Developing Rheumatoid Arthritis in Antihypertensive Patients

被引：0
|
作者：
de Jong, Hilda J. [1 ,2 ]
Vandebriel, Rob J. [1 ]
Saldi, Siti R. [3 ]
van Dijk, Liset [4 ]
van Loveren, Henk [1 ,2 ]
Tervaert, Jan Willem Cohen [2 ]
Klungel, Olaf H. [3 ]
机构：
[1] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands
[2] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[3] Univ Utrecht, Utrecht, Netherlands
[4] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
157
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [21] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy
    Dillon, JJ
    SEMINARS IN NEPHROLOGY, 2004, 24 (03) : 218 - 224
  • [22] Angioedema Related to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Nguyen, Timothy
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (09): : 690 - 691
  • [23] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan, Norman M.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (08) : 582 - 583
  • [24] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Ferrario, CM
    Jessup, J
    Chappell, MC
    Averill, DB
    Brosnihan, KB
    Tallant, EA
    Diz, DI
    Gallagher, PE
    CIRCULATION, 2005, 111 (20) : 2605 - 2610
  • [25] Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention
    Talbert, Robert L.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2010, 50 (05) : E116 - E125
  • [26] Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
    Caldeira, Daniel
    David, Claudio
    Sampaio, Cristina
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 263 - 277
  • [27] Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists
    Kyrmizakis, DE
    Papadakis, CE
    Liolios, AD
    Karatzanis, AD
    Malandrakis, S
    Skoulakis, CE
    Bizakis, JG
    Velegrakis, GA
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (12) : 1416 - 1419
  • [28] Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients
    Liu, Chia-Lin
    Shau, Wen-Yi
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF HYPERTENSION, 2012, 30 (11) : 2223 - 2229
  • [29] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on accumulation of aliskiren in the kidney
    Rahman, Asadur
    Ohmori, Koji
    Kohno, Masakazu
    Nishiyama, Akira
    JOURNAL OF HYPERTENSION, 2013, 31 (04) : 659 - 660
  • [30] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers - Reply
    Healey, JS
    Morillo, CA
    Connolly, SJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 890 - 891
12345